ABSTRACT
Mohs’ micrographic surgery may be warranted to gain clearance of the skin margins in basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs).
As the operation may be associated with significant blood loss, typed and cross-matched blood should be made available. The patient should have a full blood count, platelet count, and coagulation profile performed preoperatively. All antiplatelet agents should be discontinued 2 weeks prior to surgery. The assistance of a hematologist should be sought for the management of any patient who takes anticoagulants.
